Roche And Broad Institute Begin Multi-Year Drug-Repurposing Program
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche and the Broad Institute have teamed up to resurrect drugs that failed in mid-stage drug trials in hopes of finding new niche patient populations that could benefit from them.